Biotech Values

[RockRat]

Minor nitpick on a typo:

"LOVENOX EU Milestones*

[Guess: $48M all told.]

• Launch of generic Lovenox in any EU country. [Guess: $28M.]

• Payments on the first N anniversaries [guess: N=5] of the first launch in any EU country if there is no other generic Copaxone in the EU and the net profits from generic Copaxone in all EU countries exceed an unspecified threshold. [Guess: $20M ($4M x 5).] "

I assume you mean Lovenox where it says Copaxone in this passage.

Thanks for the guesses! All in all, the milestones seem pretty minor compared to the sales revenues involved.

Regards, RocKRat